X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Aventis Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs SANOFI INDIA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS SANOFI INDIA J.B.CHEMICALS/
SANOFI INDIA
 
P/E (TTM) x 13.5 34.5 39.2% View Chart
P/BV x 2.1 6.9 30.9% View Chart
Dividend Yield % 0.2 1.3 13.9%  

Financials

 J.B.CHEMICALS   SANOFI INDIA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
SANOFI INDIA
Dec-16
J.B.CHEMICALS/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs3184,560 7.0%   
Low Rs2004,400 4.5%   
Sales per share (Unadj.) Rs148.01,028.5 14.4%  
Earnings per share (Unadj.) Rs19.1129.0 14.8%  
Cash flow per share (Unadj.) Rs23.9186.0 12.9%  
Dividends per share (Unadj.) Rs0.5068.00 0.7%  
Dividend yield (eoy) %0.21.5 12.7%  
Book value per share (Unadj.) Rs128.9753.6 17.1%  
Shares outstanding (eoy) m84.8223.03 368.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.74.4 40.2%   
Avg P/E ratio x13.634.7 39.0%  
P/CF ratio (eoy) x10.824.1 44.9%  
Price / Book Value ratio x2.05.9 33.8%  
Dividend payout %2.652.7 5.0%   
Avg Mkt Cap Rs m21,951103,174 21.3%   
No. of employees `0002.73.6 75.5%   
Total wages/salary Rs m1,8413,592 51.3%   
Avg. sales/employee Rs Th4,590.96,537.7 70.2%   
Avg. wages/employee Rs Th673.4991.4 67.9%   
Avg. net profit/employee Rs Th592.1819.8 72.2%   
INCOME DATA
Net Sales Rs m12,55123,686 53.0%  
Other income Rs m542708 76.5%   
Total revenues Rs m13,09324,394 53.7%   
Gross profit Rs m2,0555,281 38.9%  
Depreciation Rs m4121,313 31.4%   
Interest Rs m9615 638.0%   
Profit before tax Rs m2,0884,661 44.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4691,691 27.7%   
Profit after tax Rs m1,6192,970 54.5%  
Gross profit margin %16.422.3 73.4%  
Effective tax rate %22.536.3 61.9%   
Net profit margin %12.912.5 102.9%  
BALANCE SHEET DATA
Current assets Rs m7,77815,673 49.6%   
Current liabilities Rs m4,3586,678 65.3%   
Net working cap to sales %27.238.0 71.7%  
Current ratio x1.82.3 76.0%  
Inventory Days Days5576 71.9%  
Debtors Days Days8022 358.6%  
Net fixed assets Rs m5,7138,098 70.5%   
Share capital Rs m170230 73.6%   
"Free" reserves Rs m10,54717,088 61.7%   
Net worth Rs m10,93717,356 63.0%   
Long term debt Rs m00-   
Total assets Rs m15,57425,400 61.3%  
Interest coverage x22.8311.7 7.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.9 86.4%   
Return on assets %11.011.8 93.7%  
Return on equity %14.817.1 86.5%  
Return on capital %20.026.9 74.1%  
Exports to sales %48.724.5 198.9%   
Imports to sales %7.128.0 25.3%   
Exports (fob) Rs m6,1155,801 105.4%   
Imports (cif) Rs m8896,627 13.4%   
Fx inflow Rs m6,1697,145 86.3%   
Fx outflow Rs m1,2856,846 18.8%   
Net fx Rs m4,884299 1,633.4%   
CASH FLOW
From Operations Rs m1,3973,226 43.3%  
From Investments Rs m-320-1,555 20.6%  
From Financial Activity Rs m-1,196-1,818 65.8%  
Net Cashflow Rs m-102-147 69.6%  

Share Holding

Indian Promoters % 55.4 0.0 -  
Foreign collaborators % 0.3 60.4 0.5%  
Indian inst/Mut Fund % 3.4 14.4 23.5%  
FIIs % 3.9 14.6 26.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 10.5 352.4%  
Shareholders   30,437 15,184 200.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   NATCO PHARMA  PANACEA BIOTECH  WOCKHARDT LTD.  ABBOTT INDIA  PLETHICO PHARMA  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Green; Metal Stocks Top Gainers(Closing)

After opening the day in green, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jun 20, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS